Sweden· SE-20140329000177
Intuniv 4 mg Depottablett
A medicinal product containing guanfacine, registered in Sweden by Takeda Pharmaceuticals International AG Ireland Branch.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Guanfacine
- Manufacturer
- Takeda Pharmaceuticals International AG Ireland Branch
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140329000177
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Guanfacine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesguanfacineActavis Pharma, Inc.
- United KingdomGuanfacine 4mg modified-release tabletsNeuraxpharm UK Ltd
- CanadaAPO-GUANFACINE XRAPOTEX INC
- CzechiaINTUNIVTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- IcelandIntunivTakeda Pharmaceuticals International AG Ireland Branch
- NetherlandsIntuniv 4 mg tabletten met verlengde afgifteTakeda Pharmaceuticals International AG Ireland Branch
- NorwayIntunivTakeda Pharmaceuticals International AG Ireland Branch
- PolandIntunivTakeda Pharmaceuticals International AG
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Guanfacin Neuraxpharm
- United Kingdom (Northern Ireland) · Guanfacine Crescent
- Iceland · Intuniv, Paxneury
- Liechtenstein · Intuniv, Paxneury
- Norway · Intuniv, Paxneury
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5cfe2d5-5d82-46a0-bcb3-86c83174b448 GET /v1/drugs/d5cfe2d5-5d82-46a0-bcb3-86c83174b448?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20140329000177",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140329000177",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/intuniv"
}See everything about guanfacine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.